Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they?

Serum IgG autoantibodies against the myelin oligodendrocyte glycoprotein (MOG) are present in atypical demyelinating disorders such as neuromyelitis optica spectrum disorders (NMOSD) or acute disseminated encephalomyelitis. Whereas the role of aquaporin-4 antibodies as diagnostic markers for NMOSD i...

Full description

Saved in:
Bibliographic Details
Main Authors: Reindl, Markus (Author) , Jarius, Sven (Author)
Format: Article (Journal)
Language:English
Published: June 2017
In: Current opinion in neurology
Year: 2017, Volume: 30, Issue: 3, Pages: 295-301
ISSN:1473-6551
DOI:10.1097/WCO.0000000000000446
Online Access:Verlag, Volltext: http://dx.doi.org/10.1097/WCO.0000000000000446
Verlag, Volltext: https://insights.ovid.com/pubmed?pmid=28248700
Get full text
Author Notes:Markus Reindl, Sven Jarius, Kevin Rostasy, and Thomas Berger
Description
Summary:Serum IgG autoantibodies against the myelin oligodendrocyte glycoprotein (MOG) are present in atypical demyelinating disorders such as neuromyelitis optica spectrum disorders (NMOSD) or acute disseminated encephalomyelitis. Whereas the role of aquaporin-4 antibodies as diagnostic markers for NMOSD is meanwhile well established, the role of MOG antibodies is less clear. Initial studies suggested that MOG antibodies are associated with a more benign disease course than aquaporin-4antibodies. However, recent findings challenged this view. Data from the two largest cohorts of adult MOG antibody-positive patients with the longest clinical follow-up published so far indicate that the majority of patients develop a recurrent disease course with optic neuritis as the most frequent symptom, particularly in women. Frequent attacks are often associated with accumulating damage and functional impairment. The clinical spectrum of acquired demyelinating syndromes associated with MOG antibodies seems to be broader as anticipated in prior studies, with only a third of patients fulfilling the current diagnostic criteria for NMOSD. MOG antibodies are associated with an increasing spectrum of age and sex-dependent clinical phenotypes, only partly overlapping with NMOSD and multiple sclerosis and with a high risk of a recurrent disease course.
Item Description:Gesehen am 08.05.2018
Physical Description:Online Resource
ISSN:1473-6551
DOI:10.1097/WCO.0000000000000446